| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | 0.0078 | 0.9 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |